By Media Staff | Tuesday, April 2, 2013
In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.
By Memorial Sloan-Kettering | Wednesday, March 27, 2013
Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan-Kettering have the benefit of an entire team of physicians having input into their care.
By Memorial Sloan-Kettering | Friday, March 22, 2013
To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan-Kettering for care and support that could keep him playing music and working as a personal fitness trainer.
By Memorial Sloan-Kettering | Monday, March 18, 2013
Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, March 13, 2013
Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
By Allyson Collins, MS, Science Writer/Editor | Tuesday, March 12, 2013
Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.
By Memorial Sloan-Kettering | Wednesday, March 6, 2013
Dr. Parra, who practices at Memorial Sloan-Kettering Basking Ridge, treats prostate, kidney, and bladder cancers with the goal of extending the lives of patients, and giving them the best possible quality of life.
In the Clinic
By Julie Grisham, MS, Science Writer/Editor | Monday, March 4, 2013
Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, tingling, and pain — is a common chemotherapy side effect. Treatments are available to help improve your quality of life.
By Julie Grisham, MS, Science Writer/Editor | Friday, March 1, 2013
At the seventh annual seminar for high school students and teachers, investigators discuss how cutting-edge biomedical research may ultimately contribute to better treatments for cancer patients.
By Memorial Sloan-Kettering | Wednesday, February 27, 2013
Chief of the Leukemia Service Dr. Tallman discusses how experts collaborate to deliver the most-promising therapies, and how he cares for patients as if they were members of his own family.
By Celia Gittelson, BA | Monday, February 25, 2013
Our doctors introduce and apply advanced technologies in minimal-access surgery to benefit patients.
By Media Staff | Wednesday, February 20, 2013
Charles Sawyers, Chair of Memorial Sloan-Kettering’s Human Oncology and Pathogenesis Program, is a recipient of the inaugural $3 million prize for groundbreaking achievements in scientific research.
In the News
By Jim Stallard, MA, Writer/Editor | Wednesday, February 20, 2013
Co-host Robin Roberts gives thanks to her Memorial Sloan-Kettering treatment team during her first day returning to the show after receiving a stem cell transplant.
By Eva Kiesler, PhD, Science Writer/Editor | Tuesday, February 19, 2013
Dr. Deasy, Chair of the Department of Medical Physics and an expert in radiation therapy, talks about using physics to contribute to the fight against cancer.
In the Clinic
By Media Staff | Thursday, February 14, 2013
Researchers have found that the investigational drug selumetinib shuts down the signaling of genetic mutations that prevent some patients’ thyroid cancer tumors from absorbing radioiodine, the most effective treatment for the disease.